The Journal of Nutritional Biochemistry
Volume 22, Issue 4 , Pages 360-365 , April 2011

Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice

  • Claudia Gravaghi

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Krista M.D. La Perle

      Affiliations

    • Laboratory of Comparative Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Paul Ogrodwski

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA
    • ,
  • Jing X. Kang

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    • ,
  • Fred Quimby

      Affiliations

    • Laboratory Animal Research Center, The Rockefeller University, New York, NY, USA
    • ,
  • Martin Lipkin

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA
    • ,
  • Sergio A. Lamprecht

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA

Received 7 August 2009 ,Revised 24 February 2010 ,Accepted 2 March 2010.

References 

  1. Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol. 2007;23:48–54
  2. Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, et al. Eicosapentanoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with history of colorectal adenomas. Int J Colorectal Dis. 2007;22:765–776
  3. Roynette CE, Calder PC, Dupertuis YM, Pichard C. n-3 Polyunsaturated fatty acids and colon cancer prevention. Clin Nutr. 2004;23:139–151
  4. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:1–13
  5. Chapkin RS, Davidson LA, Ly L, et al. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr. 2007;137:200S–204S
  6. Calder PC. Polyunsaturated fatty acids and inflammation. Bioch Soc Trans. 2005;33:423–427
  7. Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005;135:687–694
  8. Figler M, Gasztonvi B, Cseh J, Horvath G, Kisbenedek AG, Bokor S, et al. Association of n-3 and n-6 long-chain polyunsaturated fatty acids in plasma lipid classes with inflammatory bowel diseases. Br J Nutr. 2007;97:1154–1161
  9. Chajes V, Bougnoux C. Omega-6/omega-3 polyunsaturated fatty acids and cancer. World Rev Nutr Diet. 2003;92:133–151
  10. Newmark HI, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, et al. Western-style diet induces benign and malignant neoplasmas in the colon of normal C57BL/6 mice. Carcinogenesis. 2001;22:1871–1875
  11. Kang ZB, Ge YL, Chen ZH, Cluette-Brown J, Laposata M, Leaf A, et al. Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proc Natl Acad Sci U S A. 2001;98:4050–4054
  12. Kang JX, Wang J, Wu L, Kang ZB. Fat-1 mice convert n-6 to n-3 fatty acids. Nature. 2004;427:504
  13. Kang JX. Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins Leukot Essent Fatty Acids. 2007;77:263–267
  14. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702
  15. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/C mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1328–G1338
  16. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2009;49:123–159
  17. Wang D, Du Bois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10:181–193
  18. Kang JX, Wang JA. Simplified method for analysis of polyunsaturated fatty acids. BMC Biochemistry. 2005;6:5–9
  19. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulphate sodium experimental murine colitis. Lab Invenst. 1993;69:238–249
  20. Carothers AM, Melstrom KA, Mueller , et al. Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J Biol Chem. 2001;276:39094–40102
  21. Gravaghi C, Peppas M, Kang JX, La Perle K, Quimby F, Altholtz L, et al. Transgenic fat-1 mice convert dietary (n-6) PUFAs to (n-3) PUFAs in colonic cells. J Nutr. 2007;137:292S
  22. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A. 2006;30:11276–11281
  23. Rao CV, Simi B, Wynn TT, Garr K, Reddy BS. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res. 1996;56:532–537
  24. Malkoswki MG, Thuresson ED, Lakkides KM, Rieke J, Micielli R, Smith WL, et al. Structure of eicosapentaenoic and linolenic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem. 2001;40:37547–37555
  25. Denkis Y, Kempf D, Ferniz M, Nileshwar S, Marchetti D. Role of ω-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J Lipid Res. 2005;46:1278–1279
  26. Lim K, Han C, Xu L, Isse K, Demetris AJ, Wu T. Cyclooxygenase-2-derived Prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by ω3 polyunsaturated fatty acids. Cancer Res. 2008;68:553–560
  27. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lip Res. 2003;44:479–486
  28. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thommas LS, et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology. 2006;131:862–877
  29. Wang D, Dubois RN. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008;267:197–203
  30. Jiang GL, Nieves A, Im WB, Old DW, Dinh DT, Wheeler L. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Ther. 2007;320:22–28
  31. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883–893
  32. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23–>IL-17 axis. J Immunol. 2007;178:8138–8147
  33. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator- activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol. 2003;140(2):366–376
  34. Levy BD, Clish CB, Schimdt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612–619
  35. Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, et al. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer. 1997;73:607–612

PII: S0955-2863(10)00076-8

doi: 10.1016/j.jnutbio.2010.03.003

The Journal of Nutritional Biochemistry
Volume 22, Issue 4 , Pages 360-365 , April 2011

Article Tools

* Image Usage & Resolution